Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy

Author： Smith I.E.  

Publisher： Elsevier

ISSN： 0960-0760

Source： The Journal of Steroid Biochemistry and Molecular Biology, Vol.86, Iss.3, 2003-09, pp. : 289-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

By Ingle J.N.   Suman V.J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite

Advanced breast cancer updates on anastrozole versus tamoxifen

By Nabholtz J.M.   Arimidex Study Group  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite

'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview

By Buzdar A.U.   On behalf of ATAC trialists' group  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 399-403

Elsevier

Access to resources Recommend Favorite

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report

By Chow L.W.C.   Wong J.L.N.   Toi M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect

By Ellis M.J.   Rosen E.   Dressman H.   Marks J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 301-307

Elsevier

Access to resources Recommend Favorite